Zacks Research Weighs in on Henry Schein, Inc.’s FY2024 Earnings (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSICFree Report) – Analysts at Zacks Research raised their FY2024 EPS estimates for Henry Schein in a note issued to investors on Tuesday, April 16th. Zacks Research analyst U. Biswas now anticipates that the company will post earnings of $5.04 per share for the year, up from their previous estimate of $5.03. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share. Zacks Research also issued estimates for Henry Schein’s Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $5.38 EPS.

Several other equities analysts have also weighed in on the stock. Leerink Partnrs reiterated a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. Evercore ISI upped their price objective on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a report on Wednesday, February 28th. Jefferies Financial Group upped their target price on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, March 6th. JPMorgan Chase & Co. upped their target price on shares of Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. Finally, SVB Leerink began coverage on shares of Henry Schein in a research report on Monday, February 26th. They issued a “market perform” rating and a $78.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $81.09.

Get Our Latest Analysis on Henry Schein

Henry Schein Stock Down 1.4 %

HSIC opened at $70.20 on Wednesday. The stock has a market capitalization of $9.02 billion, a price-to-earnings ratio of 22.29, a PEG ratio of 1.75 and a beta of 0.87. The company has a fifty day moving average of $74.53 and a two-hundred day moving average of $72.50. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $85.39.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. During the same quarter in the previous year, the firm posted $1.21 earnings per share. The company’s quarterly revenue was down 10.5% on a year-over-year basis.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors have recently modified their holdings of HSIC. Cambridge Investment Research Advisors Inc. increased its position in Henry Schein by 2.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after acquiring an additional 122 shares during the period. HighTower Advisors LLC increased its holdings in Henry Schein by 18.9% in the 1st quarter. HighTower Advisors LLC now owns 14,030 shares of the company’s stock valued at $1,220,000 after buying an additional 2,226 shares during the period. MetLife Investment Management LLC increased its holdings in Henry Schein by 23.2% in the 1st quarter. MetLife Investment Management LLC now owns 37,733 shares of the company’s stock valued at $3,290,000 after buying an additional 7,095 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Henry Schein by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 18,555 shares of the company’s stock valued at $1,618,000 after buying an additional 1,149 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Henry Schein by 4.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,300,357 shares of the company’s stock valued at $113,386,000 after buying an additional 51,106 shares during the period. Institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.